Search Results - "LUTHER, T"

Enhancing Diversity and Inclusion in Clinical Trials by Corneli, Amy, Hanlen‐Rosado, Emily, McKenna, Kevin, Araojo, Richardae, Corbett, Dawn, Vasisht, Kaveeta, Siddiqi, Bernadette, Johnson, Tesheia, Clark, Luther T., Calvert, Sara B.

“…Women and people from most racial and ethnic groups in the United States have historically been under‐represented in clinical trials of investigational medical…”
Get full text

Physiological aspects of Toll‐like receptor 4 activation in sepsis‐induced acute kidney injury by Anderberg, S. B., Luther, T., Frithiof, R.

“…Sepsis‐induced acute kidney injury (SI‐AKI) is common and associated with high mortality. Survivors are at increased risk of chronic kidney disease. The…”
Get full text

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines by Grundy, Scott M, Cleeman, James I, Merz, C Noel Bairey, Brewer, Jr, H Bryan, Clark, Luther T, Hunninghake, Donald B, Pasternak, Richard C, Smith, Jr, Sidney C, Stone, Neil J

“…The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in…”
Get full text

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines by Grundy, Scott M., Cleeman, James I., Bairey Merz, C. Noel, Brewer, H. Bryan, Clark, Luther T., Hunninghake, Donald B., Pasternak, Richard C., Smith, Sidney C., Stone, Neil J.

“…The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in…”
Get full text

Increasing Diversity in Clinical Trials: Overcoming Critical Barriers by Clark, Luther T., Watkins, Laurence, Piña, Ileana L., Elmer, Mary, Akinboboye, Ola, Gorham, Millicent, Jamerson, Brenda, McCullough, Cassandra, Pierre, Christine, Polis, Adam B., Puckrein, Gary, Regnante, Jeanne M.

“…Clinical trial results provide the critical evidence base for evaluating the safety and efficacy of new medicines and medical products. Efficacy and safety may…”
Get full text

Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era by HANNAN, Edward L, RACZ, Michael, HOLMES, David R, KING, Spencer B, WALFORD, Gary, AMBROSE, John A, SHARMA, Samin, KATZ, Stanley, CLARK, Luther T, JONES, Robert H

“…The importance of completeness of revascularization by percutaneous coronary intervention in patients with multivessel disease is unclear in that there is…”
Get full text

The association between social determinants of health and patient-centred outcomes in adults with heart failure with reduced ejection fraction by Dunbar, Sandra B, Tan, Xi, Lautsch, Dominik, Maculaitis, Martine C, Ricker, Bryan, Nagle, Thomas, Clark, Luther T, Hilkert, Robert, Brady, Joanne E, Black, Heather L, Spertus, John A

“…To explore the associations between social determinants of health and patient-centred outcomes among adults with chronic heart failure with reduced ejection…”
Get full text

Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients by Gradin, A., Andersson, H., Luther, T., Anderberg, S. Bülow, Rubertsson, S., Lipcsey, M., Åberg, M., Larsson, A., Frithiof, R., Hultström, M.

“…Acute kidney injury is common in COVID-19 patients admitted to the ICU. Urinary biomarkers are a non-invasive way of assaying renal damage, and so far, urinary…”
Get full text

Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis by Dunbar, Sandra B., Tan, Xi, Lautsch, Dominik, Yang, Mei, Ricker, Bryan, Maculaitis, Martine C., Nagle, Thomas, Clark, Luther T., Hilkert, Robert, Brady, Joanne E., Spertus, John A.

“…•Patients with heart failure who had a worsening event have substantial unmet needs.•These patients have high symptom and treatment burdens and poor quality of…”
Get full text

Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components by Jean-Louis, Girardin, Zizi, Ferdinand, Clark, Luther T, Brown, Clinton D, McFarlane, Samy I

“…Although obstructive sleep apnea and cardiovascular disease have common risk factors, epidemiologic studies show that sleep apnea increases risks for…”
Get full text

Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain by TEOH, Hwee, STRAUSS, Martin H, PINSKY, David J, MARMUR, Jonathan D, SZMITKO, Paul E, VERMA, Subodh, CAVUSOGLU, Erdal, RUWENDE, Cyril, CHOPRA, Vineet, YANAMADALA, Sunitha, ENG, Calvin, CLARK, Luther T

“…To determine the prognostic value of baseline plasma adiponectin levels in patients with known or suspected coronary artery disease referred for coronary…”
Get full text

Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations by Davidson, Michael H., Maki, Kevin C., Pearson, Thomas A., Pasternak, Richard C., Deedwania, Prakash C., McKenney, James M., Fonarow, Gregg C., Maron, David J., Ansell, Benjamin J., Clark, Luther T., Ballantyne, Christie M.

“…The most recent national survey of compliance with the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) guidelines was completed…”
Get full text

Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction by Cavusoglu, Erdal, Ruwende, Cyril, Chopra, Vineet, Yanamadala, Sunitha, Eng, Calvin, Clark, Luther T., Pinsky, David J., Marmur, Jonathan D.

“…Matrix metalloproteinases and their inhibitors have been implicated in both vascular and ventricular remodeling, and in atherosclerotic plaque rupture. The…”
Get full text

Usefulness of Baseline Plasma Myeloperoxidase Levels as an Independent Predictor of Myocardial Infarction at Two Years in Patients Presenting With Acute Coronary Syndrome by Cavusoglu, Erdal, MD, Ruwende, Cyril, MD, PhD, Eng, Calvin, MD, Chopra, Vineet, MD, Yanamadala, Sunitha, PhD, Clark, Luther T., MD, Pinsky, David J., MD, Marmur, Jonathan D., MD

“…Baseline plasma myeloperoxidase (MPO) levels have been shown to independently predict the early risk of myocardial infarction (MI) in patients presenting with…”
Get full text

A Risk Score to Predict In-Hospital Mortality for Percutaneous Coronary Interventions by Wu, Chuntao, Hannan, Edward L., Walford, Gary, Ambrose, John A., Holmes, David R., King, Spencer B., Clark, Luther T., Katz, Stanley, Sharma, Samin, Jones, Robert H.

“…A Risk Score to Predict In-Hospital Mortality for Percutaneous Coronary Interventions Chuntao Wu, Edward L. Hannan, Gary Walford, John A. Ambrose, David R…”
Get full text

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines by Grundy, Scott M, Cleeman, James I, Merz, C Noel Bairey, Brewer, Jr, H Bryan, Clark, Luther T, Hunninghake, Donald B, Pasternak, Richard C, Smith, Jr, Sidney C, Stone, Neil J

“…The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in…”
Get full text

Volume-outcome relationships for percutaneous coronary interventions in the stent era by HANNAN, Edward L, CHUNTAO WU, WALFORD, Gary, KING, Spencer B, HOLMES, David R, AMBROSE, John A, SHARMA, Samin, KATZ, Stanley, CLARK, Luther T, JONES, Robert H

“…Most studies that are the basis of recommended volume thresholds for percutaneous coronary interventions (PCIs) predate the routine use of stent placement…”
Get full text

Low Plasma RANTES Levels Are an Independent Predictor of Cardiac Mortality in Patients Referred for Coronary Angiography by Cavusoglu, Erdal, Eng, Calvin, Chopra, Vineet, Clark, Luther T, Pinsky, David J, Marmur, Jonathan D

“…OBJECTIVE—Our objective was to evaluate the prognostic value of baseline plasma RANTES levels in patients with known or suspected coronary artery disease…”
Get full text

Corrigendum to ``Increasing Diversity in Clinical Trials: Overcoming Critical Barriers''. [Current Problems in Cardiology, Volume 44, Issue 5 (2019) 148–172] by Clark, Luther T., Watkins, Laurence, Piña, Ileana L., Elmer, Mary, Akinboboye, Ola, Gorham, Millicent, Jamerson, Brenda, McCullough, Cassandra, Pierre, Christine, Polis, Adam B., Puckrein, Gary, Regnante, Jeanne M.

Get full text

Usefulness of Anemia in Men as an Independent Predictor of Two-Year Cardiovascular Outcome in Patients Presenting With Acute Coronary Syndrome by Cavusoglu, Erdal, Chopra, Vineet, Gupta, Amit, Clark, Luther T., Eng, Calvin, Marmur, Jonathan D.

“…Anemia has been shown to be an independent risk factor for the development of adverse cardiovascular outcomes in a variety of patient populations. In the case…”
Get full text